15 October 2025 in Science Translational Medicine
Glucocorticoids are widely used to treat autoimmune diseases like crescentic glomerulonephritis (cGN), but their immunosuppressive functions are not fully understood. Here, we generated a single immune cell sequencing atlas at different stages of experimental cGN. We identified a proinflammatory neutrophil subset as important for disease progression and as a glucocorticoid target. Such neutrophils produced proinflammatory cytokines known to drive cGN and expressed Siglec-F and decoy tumor necrosis factor–related apoptosis-inducing ligand receptor 1 (dcTRAIL-R1) in mice and SIGLEC8 in humans. Depleting such neutrophils attenuated disease in mice, whereas their adoptive transfer aggravated disease. They differentiated within the inflamed kidney in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by clonally expanded CD4 + T helper 17 (T H 17) cells and persisted locally longer than normal neutrophils. Glucocorticoids decreased intrarenal numbers of T H 17 cells and down-regulated GM-CSF receptor expression by neutrophils and reduced their cytokine production. Selective genetic reduction of glucocorticoid receptor expression in neutrophils reenabled their in vivo differentiation during glucocorticoid therapy and aggravated cGN. Low glucocorticoid doses were sufficient to prevent intrarenal neutrophil differentiation in mice, if applied repetitively, even without an initial high-dose steroid pulse. Spatial sequencing of kidney biopsies, especially from patients with high disease activity, uncovered similar neutrophils in intrarenal inflammatory niches, and their abundance was lower after repetitive low-dose glucocorticoid application. These findings identify proinflammatory neutrophils as progression drivers in cGN and suggest that low-dose glucocorticoid therapy may be sufficient to suppress them.
20 December 2025 in Cell Death & Disease
High salt diet (HSD) is known to reduce cancer growth in some tumor models, which has been attributed to tissue accumulation of sodium that enhances local anti-tumor immunity. Here, we show that a HSD inhibits melanoma growth independent of sodium accumulation and immune cells in skin and lung. Melanoma cells from mice on a HSD upregulated the metabolic inhibitor Tuberous sclerosis complex 2 (TSC2), causing metabolic shutdown despite nutrient availability. Furthermore, Microphthalmia-associated transcription factor (MITF), a crucial regulator of melanoma metabolism and differentiation, was upregulated, resulting in enhanced melanogenesis and cell cycle arrest. Thus, a HSD reversed the de-differentiation of melanoma cells and promoted their re-differentiation into a “normal” melanocytic state. These findings suggest that the anti-tumor effect of HSD may be tumor-specific and in some cases immune cell-independent.
3 November 2024 in bioRxiv
Motivation The availability of bulk-omic data is steadily increasing, necessitating collaborative efforts between experimental and computational researchers. While software tools with graphical user interfaces (GUIs) enable rapid and interactive data assessment, they are limited to pre-implemented methods, often requiring transitions to custom code for further adjustments. However, most available tools lack GUI-independent reproducibility such as direct integration with R, resulting in very limited support for transition. Results We introduce the customizable Omics Analysis and reporting tool – cOmicsArt. cOmicsArt aims to enhance collaboration through integration of GUI-based analysis with R. The GUI allows researchers to perform user-friendly exploratory and statistical analyses with interactive visualizations and automatic documentation. Downloadable R scripts and results ensure reproducibility and seamless integration with R, supporting both novice and experienced programmers by enabling easy customizations and serving as a foundation for more advanced analyses. This versatility also allows for usage in educational settings guiding students from GUI-based analysis to R Code. Availability cOmicsArt is freely available at https://shiny.iaas.uni-bonn.de/cOmicsArt/ User documentation is available at https://icb-dcm.github.io/cOmicsArt/ Source code is available on GitHub https://github.com/ICB-DCM/cOmicsArt A docker image can be retrieved from https://hub.docker.com/r/pauljonasjost/comicsart/tags A snapshot upon publication can be found on Zenodo: https://zenodo.org/records/13740904 A screen recording of cOmicsArt is available at: https://www.youtube.com/watch?v=pTGjtIYQOakp Contact jan.hasenauer{at}uni-bonn.de Supplementary information Supplementary data are available aonline.
26 December 2024 in Bioinformatics Advances
Motivation: The availability of bulk-omic data is steadily increasing, necessitating collaborative efforts between experimental and computational researchers. While software tools with graphical user interfaces (GUIs) enable rapid and interactive data assessment, they are limited to pre-implemented methods, often requiring transitions to custom code for further adjustments. However, the most available tools lack GUI-independent reproducibility such as direct integration with R, resulting in very limited support for transition. Results: We introduce the customizable Omics Analysis and reporting tool—cOmicsArt. cOmicsArt aims to enhance collaboration through integration of GUI-based analysis with R. The GUI allows researchers to perform user-friendly exploratory and statistical analyses with interactive visualizations and automatic documentation. Downloadable R scripts and results ensure reproducibility and seamless integration with R, supporting both novice and experienced programmers by enabling easy customizations and serving as a foundation for more advanced analyses. This versatility also allows for usage in educational settings guiding students from GUI-based analysis to R Code. Availability and implementation: cOmicsArt is freely available at https://shiny.iaas.uni-bonn.de/cOmicsArt/. User documentation is available at https://icb-dcm.github.io/cOmicsArt/. Source code is available at https://github.com/ICB-DCM/cOmicsArt. A docker available from https://hub.docker.com/r/pauljonasjost/comicsart/tags. A snapshot upon publication available from https://zenodo.org/records/14907620. A screen recording of cOmicsArt is available at: https://www.youtube.com/watch?v=pTGjtIYQOakp.
8 April 2025 in JCI Insight